BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8702689)

  • 1. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling.
    Kenner KA; Anyanwu E; Olefsky JM; Kusari J
    J Biol Chem; 1996 Aug; 271(33):19810-6. PubMed ID: 8702689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin.
    Bandyopadhyay D; Kusari A; Kenner KA; Liu F; Chernoff J; Gustafson TA; Kusari J
    J Biol Chem; 1997 Jan; 272(3):1639-45. PubMed ID: 8999839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I.
    Kenner KA; Hill DE; Olefsky JM; Kusari J
    J Biol Chem; 1993 Dec; 268(34):25455-62. PubMed ID: 8244979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.
    Zhang WR; Li PM; Oswald MA; Goldstein BJ
    Mol Endocrinol; 1996 May; 10(5):575-84. PubMed ID: 8732688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats.
    Dadke SS; Li HC; Kusari AB; Begum N; Kusari J
    Biochem Biophys Res Commun; 2000 Aug; 274(3):583-9. PubMed ID: 10924321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system.
    Hashimoto N; Zhang WR; Goldstein BJ
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):569-76. PubMed ID: 1599438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities.
    Maegawa H; Ide R; Hasegawa M; Ugi S; Egawa K; Iwanishi M; Kikkawa R; Shigeta Y; Kashiwagi A
    J Biol Chem; 1995 Mar; 270(13):7724-30. PubMed ID: 7535776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases.
    Kole HK; Smyth MS; Russ PL; Burke TR
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):1025-31. PubMed ID: 7487920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of phosphatidylinositol-3-kinase by platelet-derived growth factor and insulin-like growth factor-1 is inhibited by a transmembrane phosphotyrosine phosphatase.
    Way BA; Mooney RA
    J Biol Chem; 1993 Dec; 268(35):26409-15. PubMed ID: 8253766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of dominant negative mutant SHPTP2 attenuates phosphatidylinositol 3'-kinase activity via modulation of phosphorylation of insulin receptor substrate-1.
    Ugi S; Maegawa H; Kashiwagi A; Adachi M; Olefsky JM; Kikkawa R
    J Biol Chem; 1996 May; 271(21):12595-602. PubMed ID: 8647870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway.
    Ricort JM; Binoux M
    J Biol Chem; 2002 May; 277(22):19448-54. PubMed ID: 11940579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two nonradioactive assays for phosphotyrosine phosphatases with activity toward the insulin receptor.
    Madden JA; Bird MI; Man Y; Raven T; Myles DD
    Anal Biochem; 1991 Dec; 199(2):210-5. PubMed ID: 1812786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes.
    Cicirelli MF; Tonks NK; Diltz CD; Weiel JE; Fischer EH; Krebs EG
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5514-8. PubMed ID: 2164686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s).
    Faure R; Baquiran G; Bergeron JJ; Posner BI
    J Biol Chem; 1992 Jun; 267(16):11215-21. PubMed ID: 1375938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of phosphotyrosine phosphatase expression on hormone-dependent and independent pp60c-src activity.
    Way BA; Mooney RA
    Mol Cell Biochem; 1994 Oct; 139(2):167-75. PubMed ID: 7532275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.
    Byon JC; Kusari AB; Kusari J
    Mol Cell Biochem; 1998 May; 182(1-2):101-8. PubMed ID: 9609119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
    Meyerovitch J; Backer JM; Kahn CR
    J Clin Invest; 1989 Sep; 84(3):976-83. PubMed ID: 2547842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation and activation of protein tyrosine phosphatase (PTP) 1B by insulin receptor.
    Dadke S; Kusari A; Kusari J
    Mol Cell Biochem; 2001 May; 221(1-2):147-54. PubMed ID: 11506178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.